Cargando…
Graves’ disease following administration of second dose of SARS-CoV-2 vaccine
The SARS-CoV-2 vaccines have had an overwhelming success in curbing the COVID-19 global pandemic, accounting for countless lives saved. Adverse reactions are inevitable, given the vast scale of vaccination required to mitigate future surges of COVID-19. Hyperthyroid disorders have been reported as p...
Autores principales: | Goblirsch, Timothy James, Paulson, Ambika E, Tashko, Gerti, Mekonnen, Asefa Jejaw |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719118/ https://www.ncbi.nlm.nih.gov/pubmed/34969799 http://dx.doi.org/10.1136/bcr-2021-246432 |
Ejemplares similares
-
Evidence-based approach for managing hypertension in type 2 diabetes
por: Tashko, Gerti, et al.
Publicado: (2010) -
Graves’ disease following SARS-CoV-2 vaccination
por: Sriphrapradang, Chutintorn, et al.
Publicado: (2021) -
Venous sinus thrombosis after the second dose of SARS-CoV-2 vaccine administration
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022) -
Two further cases of Graves’ disease following SARS-Cov-2 vaccination
por: Zettinig, G., et al.
Publicado: (2021) -
Graves Disease Following the SARS-CoV-2 Vaccine: Case Series
por: Weintraub, Michael A., et al.
Publicado: (2021)